Clinical trial
An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
NCT00319267 is registered in ClinicalTrials.gov with Actelion as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- An Open Label, Multicenter Study to Assess the Pharmacokinetics, Tolerability, and Safety of a Pediatric Formulation of Bosentan in Children With Idiopathic or Familial Pulmonary Arterial Hypertension
- Lead sponsor
- Actelion
- Phase
- Phase 3
- Overall status
- Completed
- Start date
- May 31, 2005
- Completion date
- February 28, 2007
- Enrollment
- 36 (actual)
- Sites
- Not reported
Conditions
As the registry lists them; a condition with its own page is linked.